The event focused on the SmartVac in-ovo vaccination system, chicken immunology and HIPRA vaccines for in-ovo application. It was attended in person by 10 delegates from Royal Pas Reform and 20 from HIPRA, together with more than 50 others participating online.
On Day 1, the HIPRA team made presentations on poultry immunology and the different vaccines they develop in the field of in-ovo. HIPRA’s latest in-ovo vaccine for coccidiosis in broilers (Evanovo®) is perfectly suitable for use with SmartVac since it requires injection into the amniotic liquid.
The group then visited the SmartVac demo unit in the HIPRA research facilities and opened vaccinated eggs in the lab to evaluate the Site of Injection (SOI): the specific location of release of the vaccine within an 18.5-day-old hatching egg. The day concluded with a visit to the SmartVac operational unit in the hatchery nearby for all to watch the machine working in real-time.
After a tour of HIPRA’s state-of-the-art HQ and R&D facilities at the start of Day 2, the specialist Pas Reform Academy team then gave presentations on embryology, hatch window, embryonic mortality and data management in the hatchery.
In addition to sharing useful information, the event was very important in allowing the two teams to get to know each other better professionally and socially, and good ideas for testing and future collaborations were discussed.
Royal Pas Reform delegate Erwin Prinzen comments: “HIPRA and Royal Pas Reform are very similar kind of companies. These events are both incredibly instructive and also very important for developing good ties between the two organizations. It ensures that we continue to collaborate in such a way that the synergies between the companies are always directed towards providing better and more effective experiences for our clients. By sharing knowledge and experiences, we will be able to better assist our customers."